CK-3773274
Showing 1 - 25 of 162
Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
- Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
- +3 more
- (no location specified)
Mar 2, 2023
Symptomatic Hypertrophic Cardiomyopathy (HCM) Trial in Italy, Spain, United States (CK-3773274 (5 - 20 mg))
Enrolling by invitation
- Symptomatic Hypertrophic Cardiomyopathy (HCM)
- CK-3773274 (5 - 20 mg)
-
Los Angeles, California
- +18 more
Jan 31, 2023
Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects Trial in Beijing (CK-3773274, Placebo)
Completed
- Obstructive Hypertrophic Cardiomyopathy
- Healthy Adult Subjects
- CK-3773274
- Placebo
-
Beijing, Beijing, ChinaClinical Site
Sep 12, 2021
Hypertrophic Cardiomyopathy (HCM) Trial in Worldwide (CK-3773274 (5 - 15 mg), CK-3773274 (10 - 30 mg), Placebo for CK-3773274)
Recruiting
- Hypertrophic Cardiomyopathy (HCM)
- CK-3773274 (5 - 15 mg)
- +2 more
-
Los Angeles, California
- +21 more
Mar 4, 2022
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy Trial in Anchorage, Portland (Aficamten, Placebo)
Recruiting
- Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
- Aficamten
- Placebo
-
Anchorage, Alaska
- +1 more
Oct 12, 2023
Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial in Worldwide (CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match
Recruiting
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
- CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg)
- Placebo to match CK-3773274
-
Anchorage, Alaska
- +31 more
Aug 9, 2022
Obstructive Hypertrophic Cardiomyopathy Trial in China (Aficamten)
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
-
Beijing, China
- +9 more
Oct 31, 2023
Symptomatic Obstructive Hypertrophic Cardiomyopathy, Healthy Subjects Trial in Tempe (CK-3773274 - Granules in Capsule, Placebo
Completed
- Symptomatic Obstructive Hypertrophic Cardiomyopathy
- Healthy Subjects
- CK-3773274 - Granules in Capsule
- +2 more
-
Tempe, ArizonaClinical Site
Jan 28, 2020
Healthy Participants Trial in Tempe (CK-4021586, Placebo for CK-4021586)
Recruiting
- Healthy Participants
- CK-4021586
- Placebo for CK-4021586
-
Tempe, ArizonaCelerion
May 17, 2023
Healthy Participants Trial in Dallas (CK-3828136, Placebo for CK-3828136)
Recruiting
- Healthy Participants
- CK-3828136
- Placebo for CK-3828136
-
Dallas, TexasLabcorp Clinical Research Unit Inc.
Dec 20, 2022
Healthy Trial in Edegem (CK-0045, Placebo)
Recruiting
- Healthy
- CK-0045
- Placebo
-
Edegem, BelgiumSGS Clinical Research, Clinical Pharmacology Unit
Jan 26, 2023
Gastrointestinal Tumors Trial in Beijing (AZD6422 CLDN18.2 CAR-T product)
Not yet recruiting
- Gastrointestinal Tumors
- AZD6422 CLDN18.2 CAR-T product
-
Beijing, ChinaBeijing Cancer Hospital
Aug 1, 2023
Diagnostic Test Trial in Sacramento (Measuring of analytes)
Recruiting
- Diagnostic Test
- Measuring of analytes
-
Sacramento, CaliforniaUC Davis
Oct 9, 2023
Total Knee Arthroplasty Trial in France (Total Knee arthroplasty)
Not yet recruiting
- Total Knee Arthroplasty
- Total Knee arthroplasty
-
Beaumont, France
- +4 more
Nov 8, 2023
Acute Myeloid Leukemia Trial in United Kingdom, United States (Arm 1: NTLA-5001, Arm 2: NTLA-5001)
Terminated
- Acute Myeloid Leukemia
- Arm 1: NTLA-5001
- Arm 2: NTLA-5001
-
Los Angeles, California
- +9 more
Oct 13, 2022
Bone Intake Proteins and Muscle Mass Deficiency in Proximal
Completed
- Femoral Neck Fractures
- +5 more
- Surgical treatment of proximal femur fracture and blood sample test
- Blood sample test
-
Warsaw, PolandDepartment of Othopedics and Rehabilitation, Medical University
Mar 26, 2023
Muscle Injury Trial in Dublin (Elio, Placebo)
Completed
- Muscle Injury
- Elio
- Placebo
-
Dublin, Leinster, IrelandNuritas Ltd
May 5, 2022
Rejection in Liver Transplant Patients
Active, not recruiting
- Liver Transplant Rejection
- Liver Transplant Failure and Rejection
- N/A-Observational Study
-
Saint Louis, MissouriSSM Health Cardinal Glennon Children's Hospital & Saint Louis Un
Nov 29, 2023
Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS
Withdrawn
- Brain and Nervous System
- (no location specified)
Jan 20, 2022
Lung Tumors, NSCLC, Carcinoma, Small Cell Trial in Worldwide (CK-301 (cosibelimab))
Recruiting
- Lung Neoplasms
- +12 more
- CK-301 (cosibelimab)
-
Wollongong, New South Wales, Australia
- +47 more
Mar 3, 2022
Cold-water Immersion, Protein-carbohydrates Supplementation, Active Recovery Trial in Puerto Real (Cold-water immersion,
Completed
- Cold-water Immersion
- +3 more
- Cold-water immersion
- +3 more
-
Puerto Real, Cadiz, SpainScience of Education Faculty
Mar 27, 2023
Inflammatory Response, Cardiac Disease Trial (Colchicine 0.5 MG, Placebo)
Not yet recruiting
- Inflammatory Response
- Cardiac Disease
- Colchicine 0.5 MG
- Placebo
- (no location specified)
Nov 1, 2023
Myocardial Damage After Cardiac Surgery
Recruiting
- Cardiac Biomarker Release
- +2 more
-
Jena, GermanyUniversitätsklinikum Jena
Sep 28, 2023